ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

181–200 of 298 studies

E2 ModerateCohortPEM not requiredCross-Sectional

NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome.

Armstrong, Christopher W, McGregor, Neil R, Sheedy, John R et al.·Clinica chimica acta; international journal of clinical chemistry·2012

Researchers used a specialized blood test called NMR to compare the levels of different chemicals in the blood of 11 people with ME/CFS and 10 healthy people. They found that people with ME/CFS had significantly lower levels of two amino acids (building blocks of protein): glutamine and ornithine. These findings suggest that people with ME/CFS may have problems with how their bodies process certain proteins and manage nitrogen, which are important for energy and cell function.

Evidence Atlas

Evidence browser

NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome.

Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression.

Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays.

Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome.

The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.

Nitric oxide concentrations are normal and unrelated to activity level in chronic fatigue syndrome: a case-control study.

Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.

Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.

Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker.

Vitamin D metabolites as clinical markers in autoimmune and chronic disease.

Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome.

Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples.

Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms.

Salivary cortisol as a predictor of postoperative fatigue.

Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research